Seven Grand Managers LLC Boosts Holdings in Heartflow, Inc. $HTFL

Seven Grand Managers LLC lifted its position in Heartflow, Inc. (NASDAQ:HTFL) by 100.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 100,000 shares of the company’s stock after acquiring an additional 50,000 shares during the quarter. Seven Grand Managers LLC’s holdings in Heartflow were worth $2,915,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Legal & General Group Plc acquired a new position in shares of Heartflow in the 3rd quarter valued at $59,000. Strs Ohio acquired a new position in shares of Heartflow in the 4th quarter valued at $99,000. Y Intercept Hong Kong Ltd acquired a new position in shares of Heartflow in the 3rd quarter valued at $234,000. Staley Capital Advisers Inc. acquired a new position in shares of Heartflow in the 4th quarter valued at $204,000. Finally, Legato Capital Management LLC acquired a new position in shares of Heartflow in the 3rd quarter valued at $243,000.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on HTFL shares. Wells Fargo & Company boosted their price target on shares of Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Friday, May 15th. JPMorgan Chase & Co. cut their price target on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a report on Thursday, March 19th. William Blair began coverage on shares of Heartflow in a report on Monday, May 4th. They issued an “outperform” rating for the company. Finally, Canaccord Genuity Group dropped their target price on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a report on Friday, May 15th. Six investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Heartflow has a consensus rating of “Moderate Buy” and an average target price of $37.00.

Insider Activity at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $28.34, for a total value of $261,266.46. Following the sale, the insider owned 78,731 shares of the company’s stock, valued at $2,231,236.54. This trade represents a 10.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $29.23, for a total transaction of $27,732,167.11. Following the completion of the sale, the insider directly owned 8,448,158 shares in the company, valued at approximately $246,939,658.34. This trade represents a 10.10% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,215,093 shares of company stock valued at $64,427,995 over the last 90 days. 7.70% of the stock is owned by corporate insiders.

Heartflow Stock Up 3.1%

Shares of NASDAQ:HTFL opened at $29.28 on Thursday. The firm’s 50 day moving average price is $28.23 and its 200 day moving average price is $28.37. The stock has a market cap of $2.53 billion and a price-to-earnings ratio of -9.41. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $41.22.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.08. The firm had revenue of $52.59 million during the quarter. The business’s revenue was up 41.3% on a year-over-year basis. On average, equities analysts anticipate that Heartflow, Inc. will post -0.78 EPS for the current year.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.